Fig. 4From: Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019Hospitalisation rate and treatment trends of myositis patients. A Analysis of the reasons for inpatient admission of myositis patients compared to the control group of the BARMER cohort (BARMER population) with relative frequencies. B Proportion of patients on glucocorticoid and other immunosuppressant therapy and/or rituximab therapy with at least one prescription per yearBack to article page